AMP-224

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameAMP-224
Drug Alias NameAMP-224AMP-244GSK-2661380
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionProgrammed cell death protein 1 blockers
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsColorectal NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmplimmune
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Cancer InstituteMedimmune Llc
Active IndicationsN/A
Inactive IndicationsColorectal NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A